看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| Nevro Corp. |
| Boston Scientific Corporation |
| Integra LifeSciences Holdings Corporation |
| Haemonetics Corporation |
| Integer Holdings Corporation |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| NVRO | BSX | IART | HAE | ITGR | ICUI | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -43% | 9% | 0% | 14% | 8% | -6% | ||
| Fiscal Year - 1 | -30% | 9% | 4% | 15% | 6% | -1% | ||
| Fiscal Year - 2 | 1% | 4% | 10% | 6% | 4% | -4% | ||
| Fiscal Year - 3 | -38% | 6% | 11% | 12% | 7% | 7% | ||
| Fiscal Year - 4 | -27% | -1% | 9% | 12% | 6% | 6% | ||
| Fiscal Year - 5 | -45% | 42% | 4% | 8% | 8% | 8% | ||
| Average | -30% | 11% | 6% | 11% | 7% | 2% | ||
| Median | -34% | 7% | 7% | 12% | 7% | 2% | ||
| Benchmarks | Ticker | |||||||
| Nevro Corp. | NYSE:NVRO | |||||||
| Boston Scientific Corporation | NYSE:BSX | |||||||
| Integra LifeSciences Holdings Corporation | NasdaqGS:IART | |||||||
| Haemonetics Corporation | NYSE:HAE | |||||||
| Integer Holdings Corporation | NYSE:ITGR | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | NVRO | BSX | IART | HAE | ITGR | ICUI | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Mar-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 409 | 16,747 | 1,611 | 1,374 | 1,717 | 2,382 | ||
| Fiscal Year | 409 | 16,747 | 1,611 | 1,309 | 1,717 | 2,382 | ||
| Fiscal Year - 1 | 425 | 14,240 | 1,542 | 1,169 | 1,556 | 2,259 | ||
| Fiscal Year - 2 | 406 | 12,682 | 1,558 | 993 | 1,331 | 2,280 | ||
| Fiscal Year - 3 | 387 | 11,888 | 1,542 | 870 | 1,221 | 1,316 | ||
| Fiscal Year - 4 | 362 | 9,913 | 1,372 | 988 | 1,073 | 1,271 | ||
| Fiscal Year - 5 | 390 | 10,735 | 1,518 | 968 | 1,258 | 1,266 | ||
| Net Income | ||||||||
| Latest Twelve Months | (113) | 1,853 | (7) | 130 | 121 | (118) | ||
| Fiscal Year | (113) | 1,853 | (7) | 118 | 121 | (118) | ||
| Fiscal Year - 1 | (92) | 1,570 | 68 | 115 | 89 | (30) | ||
| Fiscal Year - 2 | 3 | 642 | 181 | 43 | 60 | (74) | ||
| Fiscal Year - 3 | (131) | 985 | 169 | 79 | 93 | 103 | ||
| Fiscal Year - 4 | (83) | (115) | 134 | 77 | 77 | 87 | ||
| Fiscal Year - 5 | (104) | 4,700 | 50 | 55 | 91 | 101 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 636 | 35,136 | 3,782 | 2,200 | 2,943 | 4,378 | ||
| Latest Fiscal Quarter | 554 | 39,395 | 4,037 | 2,531 | 3,078 | 4,204 | ||
| Fiscal Year | 554 | 39,395 | 4,037 | 2,196 | 3,078 | 4,204 | ||
| Fiscal Year - 1 | 636 | 35,136 | 3,782 | 1,935 | 2,943 | 4,378 | ||
| Fiscal Year - 2 | 602 | 32,469 | 3,890 | 1,860 | 2,794 | 4,516 | ||
| Fiscal Year - 3 | 575 | 32,229 | 3,782 | 1,820 | 2,582 | 1,881 | ||
| Fiscal Year - 4 | 789 | 30,777 | 3,615 | 1,267 | 2,372 | 1,764 | ||
| Fiscal Year - 5 | 470 | 30,565 | 3,303 | 1,275 | 2,353 | 1,692 | ||
| Fiscal Year - 6 | 463 | 20,999 | 3,108 | 1,237 | 2,327 | 1,585 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 293 | 19,282 | 1,588 | 943 | 1,519 | 2,123 | ||
| Latest Fiscal Quarter | 231 | 21,770 | 1,545 | 907 | 1,619 | 1,965 | ||
| Fiscal Year | 231 | 21,770 | 1,545 | 960 | 1,619 | 1,965 | ||
| Fiscal Year - 1 | 293 | 19,282 | 1,588 | 818 | 1,519 | 2,123 | ||
| Fiscal Year - 2 | 324 | 17,573 | 1,804 | 749 | 1,417 | 2,090 | ||
| Fiscal Year - 3 | 304 | 16,622 | 1,685 | 732 | 1,355 | 1,616 | ||
| Fiscal Year - 4 | 388 | 15,326 | 1,515 | 587 | 1,271 | 1,502 | ||
| Fiscal Year - 5 | 216 | 13,877 | 1,417 | 668 | 1,152 | 1,377 | ||
| Fiscal Year - 6 | 245 | 8,726 | 1,376 | 752 | 1,060 | 1,264 | ||